Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Life Insurance Co ( (HK:2628) ) has shared an update.
China Life Insurance Company Limited reported modest balance sheet growth in the first quarter of 2026, with total assets rising 1.6% from year-end 2025 to RMB 7.72 trillion and equity attributable to shareholders edging up 0.5% to RMB 598.26 billion. The figures were prepared under China Accounting Standards for Business Enterprises and remain unaudited, with senior management affirming the accuracy and completeness of the data.
Profitability weakened significantly over the period, as operating income fell 15.3% year on year to RMB 93.29 billion and net profit attributable to equity holders dropped 32.3% to RMB 19.51 billion, driving earnings per share down to RMB 0.69. Net cash inflow from operating activities declined 8.9% to RMB 175.43 billion and weighted average return on equity slid to 3.27%, indicating pressure on returns despite stable capital levels and underscoring a more challenging earnings environment for the insurer and its shareholders.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$33.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Company Limited is a major Chinese life insurer, operating as a joint stock company incorporated in the People’s Republic of China and listed in Hong Kong. The group focuses on life insurance and related financial services, managing a large asset base and serving policyholders across the mainland Chinese market.
Average Trading Volume: 60,458,423
Technical Sentiment Signal: Buy
Current Market Cap: HK$1076.1B
For an in-depth examination of 2628 stock, go to TipRanks’ Overview page.

